Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

University of Michigan forms chronic kidney disease consortium with pharma companies The University of Michigan (U-M) has established a chronic kidney disease (CKD) consortium with several pharmaceutical companies, including AstraZeneca and Eli Lilly and Company. Drug Research > Drug Discovery & Development > News
NanoViricides inks deal with University of Pittsburgh for ocular resting of drug candidates NanoViricides has entered into an agreement with the University of Pittsburgh for the testing of its nanoviricides drug candidates in standard animal models of ocular virus infections.
Contract Research & Services > Contract Services > News ONL Therapeutics gets FDA orphan drug designation for ONL1204 to treat retinal detachment The US Food and Drug Administration (FDA) has granted orphan drug designation to ONL Therapeutics' ONL1204 for the treatment of retinal detachment.
Regulatory Affairs > News Crown Bioscience to commercialize University of York's prostate cancer models Crown Bioscience has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.
Drug Research > Drug Discovery & Development > News
RedHill Biopharma completes pharmacokinetic study with BEKINDA 12 mg formulation RedHill Biopharma has completed a first-in-man pharmacokinetic (PK) study of BEKINDA 12 mg formulation, intended to be administered in the Phase II study for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).
Contract Research & Services > Clinical Trials > News EMA accepts Sandoz application for biosimilar to Amgen's Neulasta cancer drug By PBR Staff Writer
The European Medicines Agency (EMA) has accepted an application to review Sandoz's biosimilar to Amgen's EU-licensed Neulasta (pegfilgrastim) cancer drug.
Production & Manufacturing > Process & Production > News Incyte to stop Janus studies of Ruxolitinib in solid tumor cancers By PBR Staff Writer
Incyte said it will stop Janus studies of ruxolitinib plus capecitabine in patients with advanced or metastatic pancreatic cancer after the treatment's effectiveness was found to be insufficient.
Contract Research & Services > Clinical Trials > News

Latest News and Insight by Sector

Production & Manufacturing

EMA accepts Sandoz application for biosimilar to Amgen's Neulasta cancer drug
By PBR Staff Writer
The European Medicines Agency (EMA) has accepted an application to review Sandoz's biosimilar to Amgen's EU-licensed Neulasta (pegfilgrastim) cancer drug.
Production & Manufacturing > Process & Production > News
Lonza, Renova sign manufacturing deal for clinical supply of RT-100 gene therapy
Lonza Houston and Renova Therapeutics have entered into a Manufacturing Services Agreement to develop a scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug Product for use in Renova’s future clinical trials.
Production & Manufacturing > Manufacturing > News

Drug Research

Crown Bioscience to commercialize University of York's prostate cancer models
Crown Bioscience has reached an agreement with UK’s University of York to exclusively license and commercialize the university’s unique collection of patient-derived xenograft (PDX) models for prostate cancer.
Drug Research > Drug Discovery & Development > News
University of Michigan forms chronic kidney disease consortium with pharma companies
By PBR Staff Writer
The University of Michigan (U-M) has established a chronic kidney disease (CKD) consortium with several pharmaceutical companies, including AstraZeneca and Eli Lilly and Company.
Drug Research > Drug Discovery & Development > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

NanoViricides inks deal with University of Pittsburgh for ocular resting of drug candidates
NanoViricides has entered into an agreement with the University of Pittsburgh for the testing of its nanoviricides drug candidates in standard animal models of ocular virus infections.
Contract Research & Services > Contract Services > News
RedHill Biopharma completes pharmacokinetic study with BEKINDA 12 mg formulation
RedHill Biopharma has completed a first-in-man pharmacokinetic (PK) study of BEKINDA 12 mg formulation, intended to be administered in the Phase II study for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D).
Contract Research & Services > Clinical Trials > News

Automation

Bayer HealthCare selects Oracle solutions to manage clinical monitoring processes
By PBR Staff Writer
Bayer HealthCare, a subgroup of Bayer, has selected two of Oracle's health sciences offerings to oversee and manage its clinical monitoring processes.
Automation > IT & Software > News
AAI/CML unveil new offering for solid state chemistry and formulation development
AAIPharma Services Corp. / Cambridge Major Laboratories (AAI/CML) has announced today an integrated service offering for solid state chemistry and formulation development to help the pharma/biotech industry meet important milestones and maintain stability in drug development.
Automation > IT & Software > News

Regulatory Affairs

ONL Therapeutics gets FDA orphan drug designation for ONL1204 to treat retinal detachment
The US Food and Drug Administration (FDA) has granted orphan drug designation to ONL Therapeutics' ONL1204 for the treatment of retinal detachment.
Regulatory Affairs > News
Amarantus gets FDA orphan drug designation for Eltoprazine to treat PD-LID
Amarantus BioScience has received orphan drug designation from the US FDA for Eltoprazine in the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID).
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery